Selected novel anti-CD20 antibodies in clinical development.
| Agent . | Clinical trial setting . | Ref. . |
|---|---|---|
| HuMax-CD20 (Genmab S/A) | Follicular NHL, CLL Rheumatoid arthritis | 16,17 |
| PRO70769 (Genentech, Inc) | Rheumatoid arthritis | 18 |
| IMMU-106 (hA20) (Immunomedics, Inc) | NHL | 20 |
| Agent . | Clinical trial setting . | Ref. . |
|---|---|---|
| HuMax-CD20 (Genmab S/A) | Follicular NHL, CLL Rheumatoid arthritis | 16,17 |
| PRO70769 (Genentech, Inc) | Rheumatoid arthritis | 18 |
| IMMU-106 (hA20) (Immunomedics, Inc) | NHL | 20 |